Login / Signup

CLinical EValuation of WEB 17 device in intracranial aneuRysms (CLEVER): 1-year effectiveness results for ruptured and unruptured aneurysms.

Laurent SpelleVincent CostalatJildaz CaroffFritz WodargSebastian FischerDenis HerbreteauMarkus A MöhlenbruchAnne-Christine JanuelChrisanthi PapagiannakiJoachim KlischJussi NumminenRiitta RautioAnsgar BerlisCristian MihaleaVanessa ChalumeauJohnathan DownerJonathan CorteseLeon IkkaSophie GallasMaxim BesterThomas LiebigStéphane VelascoLamiae GrimaldiJames ByrneIstvan SzikoraLaurent PierotChristophe Cognard
Published in: Journal of neurointerventional surgery (2024)
Aneurysm diameters ranged from 2.0 to 9.2 mm, with 95.7% being broad-based (dome-to-neck ratio <2). Follow-up imaging at 1 year was completed for 146 out of 163 subjects (89.6%) and evaluated by an independent core laboratory. The primary efficacy endpoint of adequate occlusion without re-treatment at 1 year was achieved for 120 (82.2%) of all subjects. At 1 year, the adequate occlusion rate was 86.5% for ruptured aneurysms (73.1% complete occlusion) and 82.4% for unruptured aneurysms (57.1% complete occlusion). The overall re-treatment rate at 1 year was 2.6% (4/152), with 3.1% (3/97) for unruptured aneurysms and 1.8% (1/55) for ruptured aneurysms CONCLUSION: Delivery of the WEB 17 via 0.017 inch catheters represents a significant evolution of the WEB design. The results of CLEVER presented here demonstrate that it maintains the same efficacy as previous generations of WEB.
Keyphrases